SCHEMBL4711825

SCHEMBL4711825

C[Si](C)(C)CCOCc1cccc2[nH]c(CO)nc12

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CHEK1 O14757 1/20 0.35
▸ RHEB Q15382 2/20 0.33
▸ GRIN1 Q05586 1/20 0.33
▸ GRIN2B Q13224 1/20 0.33
▸ PARP1 P09874 1/20 0.32
▸ MGAM O43451 2/20 0.32
▸ GAA P10253 2/20 0.32
▸ SI P14410 2/20 0.32
▸ MGAM2 Q2M2H8 2/20 0.32
▸ HTR6 P50406 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.31
▸ RET P07949 1/20 0.31
▸ HCAR2 Q8TDS4 1/20 0.31
▸ NPC1 O15118 2/20 0.31
▸ RAB9A P51151 2/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4715459 0.79 ADAMTS5 (0.33) RETHCAR2
SCHEMBL6681270 0.76 CHEK1 (0.45) CHEK1RHEBPARP1HTR6TDP1
SCHEMBL15767459 0.74 CACNA1H (0.43) CHEK1GRIN1GRIN2BPARP1HTR6
SCHEMBL4346855 0.73 MGAM (0.51) MGAMGAASIMGAM2TDP1
SCHEMBL11498419 0.70 LIPG (0.40) CHEK1
SCHEMBL30648520 0.70 NPC1 (0.55) GAATDP1NPC1RAB9ASMN1; SMN2
SCHEMBL569633 0.70 NPC1 (0.55) GAATDP1NPC1RAB9ASMN1; SMN2
SCHEMBL31555757 0.69 CYP2C9 (0.46) HCAR2NPC1RAB9ASMN1; SMN2
SCHEMBL15767180 0.69 CHEK1 (0.41) CHEK1PARP1HTR6
SCHEMBL9589046 0.69 GRIN1 (0.49) CHEK1RHEBGRIN1GRIN2BPARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465889-A4 CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS WITH ENHANCED EFFICACY ANORMED INC (CA) 2008-05-14 — — EP disclosed
EP-1628533-A2 CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS WITH ENHANCED EFFICACY ANORMED INC. (CA) 2006-03-01 — — EP disclosed
WO-2004106493-A2 CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS WITH ENHANCED EFFICACY ANORMED INC. (CA) 2004-12-09 — — WO disclosed
EP-1465889-A1 CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS WITH ENHANCED EFFICACY AnorMED Inc. (CA) 2004-10-13 — — EP disclosed
WO-2003055876-A1 CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS WITH ENHANCED EFFICACY ANORMED INC. (CA) 2003-07-10 — — WO disclosed
Send feedback